Jean Zeghondy: Our work on Tucatinib combination post Trastuzumab-Deruxtecan in HER2+ Metastatic Breast Cancer published in JAMA Network Open

Jean Zeghondy: Our work on Tucatinib combination post Trastuzumab-Deruxtecan in HER2+ Metastatic Breast Cancer published in JAMA Network Open

Jean Zeghondy, Associate Practitioner at the Breast Cancer Unit at Gustave Roussy, shared a post on LinkedIn:

“Our work on Tucatinib combination post Trastuzumab-Deruxtecan in HER2+ Metastatic Breast Cancer published in JAMA Network Open.”

Jean Zeghondy: Our work on Tucatinib combination post Trastuzumab-Deruxtecan in HER2+ Metastatic Breast Cancer published in JAMA Network Open

Read further.
Source: Jean Zeghondy/LinkedIn

cancer Gustave Roussy JAMA Network Open Jean Zeghondy metastatic breast cancer OncoDaily Oncology Trastuzumab deruxtecan Tucatinib